Former Chief Scientific Officer · Sage Therapeutics, Inc. (SAGE)

Albert Robichaud

A named executive officer of Sage Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$3,913,495

Salary $381,259Stock awards $1,787,201

FY2022: $1,588,053

2nd of 7 named executive officers at Sage Therapeutics by FY2023 total.

7 named officers on file for Sage Therapeutics, FY2023

Albert Robichaud’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 15 equity grants, each cited to its filing
  • SAGE’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Sage Therapeutics’s whole pay program stands against its peers

  • Sage Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SAGE→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 24, 2024 (DEF 14A).

Free

Get Albert Robichaud’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Albert Robichaud compensation by year

Sage Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Sage Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023
Salary$457,660$500,223$381,259
Bonus$0$26,262$0
Stock awards$925,538$466,984$1,787,201
Option awards$1,208,940$372,563$800,913
Non-equity incentive$192,218$210,093$0
Pension and deferred compensation$0$0$0
All other$11,806$11,928$944,122
Total$2,796,162$1,588,053$3,913,495

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sage Therapeutics, Inc. DEF 14A filed April 24, 2024, accession 0001193125-24-110075, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Sage Therapeutics, Inc. filed document, accession 0001193125-24-110075. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2024.

$2.8M
$1.6M
$3.9M
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
PSU13,640$295,579—
PSU10,850$235,120—
PSU7,875$170,651—
PSU7,500$162,525—
Option833—$68.87
Option6,562—$82.27
Option7,204—$43.04
Option16,720—$45.28

Per the Outstanding Equity Awards at Fiscal Year-End table in Sage Therapeutics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Sage Therapeutics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Barry GreeneChief Executive Officer and President$6,237,491
Albert Robichaud · this pageFormer Chief Scientific Officer$3,913,495
Christopher BenecchiChief Business Officer$2,280,917
Anne Marie CookSenior Vice President, General Counsel$2,150,623
Kimi IguchiFormer Chief Financial Officer and Treasurer$1,984,101
Gregory ShifermanSenior Vice President, General Counsel and Secretary$1,318,968
Laura GaultFormer Chief Medical Officer$1,274,325

The full Sage Therapeutics compensation record

free company brief

This page is one person within Sage Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Sage Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Sage Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Albert Robichaud's compensation dossier · One-time report. No refunds.